ACI Biosciences Email Formats
Research Services • 
Friendship Heights Village, Maryland, United States • 21-50 Employees
ACI Biosciences Email Formats
ACI Biosciences uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@animalci.com), used 53.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@animalci.com | 61.5% |
{first name}{last name} | johndoe@acibiosciences.com | 26.9% |
{last name}{last name} | doedoe@animalci.com | 11.5% |
Key Contacts at ACI Biosciences
Elizabeth Kee
Senior Director, Clinical Development And Study Operations
Kristen Khanna
Chief Executive Officer
Terri Wasmoen
Executive Director, Biologicals
Tiffany Prentice
Senior Director, Analytical Development And Qc - Cmc
Renee Frey
Senior Director Systems And Compliance
Niki Waldron
Executive Director - Chemistry, Manufacturing And Controls Cmc
Christie Braun-Hammelman
Director Clinical Development
Regina Jensen
Director Clinical Development
Eden Bermingham
Excecutive Director, Pharmacology And Product Development
Stephanie Pierce
Director Clinical Development
Company overview
| Headquarters | 4445 Willard Avenue, 6th floor, Chevy Chase, MD 20815, US |
| Phone number | +13018410014 |
| Website | |
| NAICS | 5417 |
| Founded | 2000 |
| Employees | 21-50 |
| Socials |
About ACI Biosciences
ACI Biosciences has expanded its offering to connect demand with expertise in many areas of new animal drug development, including but not limited to Chemistry, Manufacturing and Controls (CMC); Target Animal Safety (TAS), Target Animal Effectiveness (TAE) and Regulatory Affairs (Center for Veterinary Medicine (CVM), USDA-Center for Veterinary Biologics, Health Canada’s Veterinary Drugs Directorate (VDD), the Japanese Ministry of Agriculture, Forestry and Fisheries’, the European Medicines Agency (EMA) and the Ministério da Agricultura, Pecuária e Abastecimento (MAPA) in Brazil). Since its inception, ACI Biosciences has successfully worked in partnership with pet owners and veterinarians, bridging the veterinary community with pharmaceutical and biotechnology companies to develop novel treatments for pets with cancer and other diseases and conditions. ACI Biosciences' reputation is built on its ability to effectively collaborate with its network of veterinarians and subject matter experts, who are leaders in their respective fields. ACI Biosciences has helped many companies develop new products and bring to market safe and effective therapies for pets. The ACI Biosciences team today has decades of experience acquired working for veterinary practices and universities, for large animal health and human health companies, as well as for CVM. We closely collaborate with Sponsors, providing timely and synchronized access to subject matter experts, building and leading talented new product development teams. ACI Biosciences supports the conduct of field effectiveness and safety studies from proof-of-concept to pivotal studies, providing services from protocol writing, to biostatistical plans and analyses, to submission of the studies to regulatory agencies. ACI Biosciences also has the ability to incorporate extensive Research and Development and regulatory know-how into successful product development strategy and execution.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
ACI Biosciences has 21 employees across 9 departments.
Departments
Number of employees
Funding Data
ACI Biosciences has never raised funding before.
ACI Biosciences Tech Stack
Discover the technologies and tools that power ACI Biosciences's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
JavaScript libraries
JavaScript libraries
Marketing automation
Page builders
JavaScript libraries
Web servers
SEO
JavaScript libraries
JavaScript libraries
Japan
United Kingdom
France
Italy
NetherlandsFrequently asked questions
4.8
40,000 users
